Switzerland-based chocolate company Nestlé has acquired a portfolio company from a venture capital firm it invests in. Nestlé’s Health Science division, which was set up last year after information about disease-fighting nutrition provided by venture capital firm Inventages Group, has acquired CM&D Pharma, which provides chewing gum, called Fostrap for people with kidney disease, inflammatory…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
